DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis
Status:
Completed
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
This is a 3-arm, prospective, randomized, double-blind, and controlled study of DLBS1442 for
the treatment of pain in patients suspected endometriosis. It is hypothesized that the
reduction of the composite-pain intensity (as measured by VAS) from baseline to the end of
study (week 8th) resulting from administration of DLBS1442, regardless of the dosage regimen,
is significantly greater than that of Control. In addition, the administration of DLBS1442 at
higher dose also results in significantly greater reduction than that of DLBS1442 at lower
dose and of Control.